• NIA Innovations & COVID-19
  • Newsletter Sign-Up
  • FAQs
  • Case Studies
  • Contact Us
NIANIANIANIA
  • About
    • What the NIA offers
    • Selection Process
    • Core Team
    • Mentors
    • Partners
    • Collaborate
    • Apply
  • Fellows and Innovations
    • Overview
    • Fellows
    • Innovations
    • Alumni
  • Latest
    • Events
    • News & blogs

Congenica earns major role in supporting world’s first routine national genomic medicine service

    Home News Congenica earns major role in supporting world’s first routine national genomic medicine service
    NextPrevious

    Congenica earns major role in supporting world’s first routine national genomic medicine service

    By admin | News | Comments are Closed | 18 October, 2018 | 0

    Congenica has been awarded a multi-year contract by Genomics England, to be a provider of Diagnostic Decision Support Services for them to deliver for the world leading NHS Genomic Medicine Service.

    Genomics England carried out a rigorous evaluation of all the leading providers of diagnostic decision support solutions for genomics from across the globe, during a formal competitive tender process. Features including usability, clinical accuracy, case throughput and commercial value were all tested, and Congenica’s platform Sapientia emerged as the clear leader.

    Sapientia was one of the first innovations selected for the NHS Innovation Accelerator (NIA) in 2015. Fellow, Andrea Haworth, Head of Clinical Service at Congenica, has been supported by the NIA to spread Sapientia across England’s NHS over the past three years.

    Professor John Mattick, Chief Executive of Genomics England, commented:

    “By working with Congenica from the start of the 100,000 Genomes Project, we’ve been able to provide high quality variant interpretation of genome sequences to the NHS, helping deliver benefits to patients at scale. Now that we are embarking on the next exciting step in our journey to embed genomic medicine in healthcare, Congenica will continue to play an important role with Genomics England in delivering results to clinicians and diagnoses to patients.”

    The NHS is establishing the national Genomic Medicine Service inclusive of a network of Genomic Laboratory Hubs around the country serving patients with a wide variety of needs. Initially, patients who suffer with rare and inherited diseases and cancer will be able to access genomic testing – an area of focus for the Sapientia platform. The service began mobilising in October 2018 and will continue to provide valuable clinical information to 100,000s of patients.

    Congenica’s CEO, Dr David Atkins said:

    “Genomics England and the NHS have done extraordinary work in building the foundations for the Genomic Medicine Service. We feel privileged to continue to be part of this initiative and to be a contributor to the world’s first service of this kind. While we have many other customers who have subjected us to rigorous evaluation, we are particularly proud to have beaten a very competitive field in this competition.”

    Sapientia, has already been extensively validated on approximately 10,000 genomes during the 100,000 Genomes Project. During this time, Congenica’s clinical scientists used Sapientia for clinical analysis and genomic interrogation, to generate comprehensive, actionable clinical reports.

    Genomics England was established by the UK Department of Health and Social Care to deliver the 100,000 Genomes Project, which is expected to complete before the end of 2018. The learnings from this project have enabled the NHS to advance a service which transforms the way that people are cared for in the UK, bringing genomics to the clinic and improving the quality and efficiency of the healthcare system.

    No tags.

    Related Posts

    • The new palliative care gold standard

      By admin | Comments are Closed

      By: Julia Riley The EIU’s recent Quality of Death report praised palliative care in the UK as the best in the world, citing the quality and availability of services provided by the NHS and hospice movement as “second toRead more

    • Nervecentre Software win prestigious Building Better Healthcare Award

      By admin | Comments are Closed

      Nervecentre Software in partnership with Nottingham University Hospitals NHS Trust have won the prestigious award for ‘Best Communications and IT product’ at the Building Better Healthcare Awards, held on 4th November 2015, The award isRead more

    • Southend University Hospital NHS Foundation Trust live with Nervecentre electronic observations

      By admin | Comments are Closed

      Southend University Hospital NHS Foundation Trust has now deployed Nervecentre Electronic Observations software using mobiles devices across the hospitals to improve patient safety and communications. Funded through the Nursing Technology Fund, Electronic Observations are now liveRead more

    • Nervecentre in Australia… Success at the ISRRS Symposium in Melbourne


      By admin | Comments are Closed

      Written by Jim Trueman Attendees of the symposium held by the International Society for Rapid Response Systems and Medical Emergency Teams are all clinicians that intuitively recognise the problems that Nervecentre was designed to solve. Read more

    • i-THRIVE: Manchester and Salford’s Integrated Access and Care Pathways 


      By admin | Comments are Closed

      What was the problem you were trying to solve? Central Manchester University Hospitals NHS Foundation Trust (CMFT) provide child and adolescent mental health services (CAMHS) for Manchester and Salford. The move towards Integrated Access andRead more

    • Coordinate My Care Integrates Care Plans into Emis Web

      By admin | Comments are Closed

      Urgent care plans for thousands of London’s most vulnerable patients care are now just a click away for almost 1,000 of their GPs. Plan sharing scheme Coordinate my Care will now be available to 962Read more

    • OWise breast cancer app proven to be effective tool in cancer treatment process

      By admin | Comments are Closed

      Innovative patient support app shown in peer-reviewed medical journal to improve patient-doctor interactions and is recommended by 90% of patients and clinicians OWise breast cancer, the first mobile app to offer patients personalised medical supportRead more

    • OBH featured in TeleMedicine Magazine

      By admin | Comments are Closed

      Telemedicine Magazine included an article on Outcome Based Healthcare (OBH) in their series focusing on the growing trend of doctors getting involved with healthcare start-ups. Rupert, OBH CEO, explained that during his time as aRead more

    NextPrevious
    Contact Us
    nia@uclpartners.com
    @NHSAccelerator
    Newsletter Sign-Up
    Terms and Conditions | Privacy and Cookies
    NHS Innovation Accerlator
    Copyright 2017 NHS Innovation Accelerator
    • Menu
      • Latest
      • Case Studies
      • News and Events
      • Press and Media
      • FAQs (OLD)
      • Contact Us
    • Apply
    • Fellows and Innovations
      • Fellows
      • Innovations
    • Collaborate
    • Accelerator
      • Partners
      • What the NIA offers
      • Selection Process
      • Mentors
    NIA